GCC Hemorrhoids Surgical Devices Market Size, Share, Trends and Forecasts 2031

Key Findings

• The GCC Hemorrhoids Surgical Devices Market is expanding as the preference for minimally invasive hemorrhoid treatments increases across hospital and outpatient settings.

• Rising adoption of stapled hemorrhoidopexy, laser hemorrhoidoplasty, and doppler-guided procedures is driving demand for specialized surgical devices in GCC.

• Technological advancements in energy-based devices, staplers, and ligation systems are improving patient outcomes and reducing postoperative pain.

• Growing awareness and reduced social stigma around anorectal disorders are leading to higher treatment-seeking rates and procedural volumes.

• Ambulatory surgical centers in GCC are increasingly equipped for day-care hemorrhoid surgeries, boosting device utilization outside large hospitals.

• Aging populations, sedentary lifestyles, and dietary factors are contributing to higher hemorrhoid prevalence, supporting long-term market growth.

• High procedure and device costs, along with uneven access to skilled colorectal surgeons, remain key challenges in certain regions of GCC.

• Collaborations between device manufacturers and colorectal surgery societies are promoting training, technique standardization, and technology adoption in GCC.

GCC Hemorrhoids Surgical Devices Market Size and Forecast

The GCC Hemorrhoids Surgical Devices Market is projected to grow from USD 1.1 billion in 2025 to USD 2.0 billion by 2031, at a CAGR of 10.6% during the forecast period. This growth is supported by increasing adoption of minimally invasive and day-care hemorrhoid procedures that require specialized devices such as circular staplers, energy-based systems, and ligation instruments. Hospitals and ambulatory surgical centers are investing in advanced proctology suites to handle rising patient volumes, particularly for grade II–IV hemorrhoids that are unresponsive to conservative management. Improved diagnostic capabilities and heightened patient awareness in GCC are further increasing the number of patients opting for definitive surgical treatment. As clinical guidelines increasingly favor less invasive, pain-reducing approaches, the demand for technologically advanced hemorrhoids surgical devices will continue to strengthen.

Introduction

Hemorrhoids surgical devices are used to perform operative interventions for symptomatic internal and external hemorrhoids, particularly when lifestyle changes and pharmacologic therapies fail. These devices include staplers for hemorrhoidopexy, doppler-guided ligation systems, infrared and laser coagulation devices, rubber band ligation tools, electrosurgical units, and associated proctoscopes and anoscopes. In GCC, the burden of hemorrhoidal disease is rising due to factors such as sedentary habits, obesity, pregnancy, chronic constipation, and aging demographics. As patients seek faster relief and shorter recovery times, surgeons are increasingly adopting minimally invasive, device-dependent techniques. This shift is reshaping procedural protocols, capital budgeting, and training priorities across colorectal surgery and general surgery departments in GCC.

Future Outlook

By 2031, the GCC Hemorrhoids Surgical Devices Market is expected to transition further toward highly standardized, minimally invasive, and patient-centric treatment pathways. Day-care surgeries using stapled and energy-based procedures will become routine in both tertiary hospitals and high-volume ambulatory centers. Device innovation will focus on reducing postoperative pain, accelerating return to normal activities, and minimizing recurrence rates. Single-use, infection-controlled instruments will see wider adoption as infection prevention becomes a stronger regulatory and clinical focus. Digital integration, including procedure analytics, training simulations, and image-guided anoscopy, will enhance precision and reproducibility. As reimbursement frameworks in GCC adapt to recognize the advantages of minimally invasive hemorrhoid surgery, the market will be positioned for sustained, technology-driven expansion.

GCC Hemorrhoids Surgical Devices Market Trends

• Shift Toward Minimally Invasive Hemorrhoid Procedures
  Surgeons in GCC are increasingly favoring minimally invasive hemorrhoid procedures such as stapled hemorrhoidopexy, laser hemorrhoidoplasty, and doppler-guided ligation over traditional excisional hemorrhoidectomy. These techniques are associated with reduced postoperative pain, shorter hospital stays, and quicker return to daily activities, which strongly influences both patient and clinician preference. As evidence accumulates supporting favorable outcomes, hospitals are updating clinical protocols to incorporate these device-intensive methods. The demand for circular staplers, laser probes, and specialized ligation systems is rising in line with this procedural shift. Over time, minimally invasive techniques are expected to dominate the case mix for surgically managed hemorrhoids in GCC.

• Rising Adoption of Energy-Based and Laser Systems
  Energy-based systems, including radiofrequency and laser devices, are gaining traction for hemorrhoid treatment in GCC due to their precision and hemostatic benefits. These systems allow targeted tissue shrinkage with minimal collateral damage, leading to less postoperative discomfort and fewer complications. Clinics and hospitals that position themselves as advanced proctology centers are particularly keen on investing in such technologies to differentiate their service offerings. Training programs are evolving to include hands-on experience with laser and radiofrequency equipment, expanding the pool of surgeons familiar with these modalities. As device costs gradually come down and evidence supports long-term efficacy, energy-based platforms will become an integral segment of the hemorrhoids device landscape.

• Growth of Ambulatory and Day-Care Proctology Centers
  There is a noticeable trend in GCC toward performing hemorrhoid surgeries in ambulatory surgical centers and specialized day-care proctology units. These facilities are designed for high throughput, cost-effective care and often specialize in minimally invasive procedures that enable same-day discharge. As healthcare systems strive to reduce inpatient loads and overall procedure costs, the move to ambulatory settings becomes increasingly attractive. This trend drives demand for compact, efficient, and user-friendly surgical devices that can be easily integrated into smaller operating rooms. The proliferation of such centers expands access to device-based hemorrhoid treatments beyond large metropolitan hospitals, widening the addressable market.

• Standardization of Techniques and Clinical Guidelines
  Professional colorectal and surgical societies in GCC are increasingly issuing guidelines and consensus statements on appropriate technique selection for different grades of hemorrhoids. This process of standardization encourages the adoption of evidence-backed devices and discourages inconsistent use of outdated techniques. As guideline-driven practice becomes more prevalent, device manufacturers benefit from clearer procedure pathways and volume predictability. Hospitals and payers also gain confidence in investing in recommended technologies that align with best-practice standards. Over time, standardized protocols will reinforce the use of specific classes of staplers, ligation devices, and energy systems, consolidating market demand in favor of clinically validated solutions.

• Increased Patient Awareness and Earlier Intervention
  Public awareness campaigns, better access to gastrointestinal and colorectal consultations, and reduced stigma around anorectal symptoms are leading to earlier presentation of hemorrhoid cases in GCC. Patients are more willing to discuss symptoms such as bleeding, discomfort, and prolapse, which results in timely referrals for potential minimally invasive treatment. Earlier-stage cases can often be managed with less invasive, device-based procedures, generating steady demand for ligation and coagulation instruments. As patients increasingly seek procedures with short recovery periods and minimal pain, clinicians recommend device-supported options that meet these expectations. This shift in patient behavior is a subtle but powerful driver of surgical device utilization for hemorrhoids.

Market Growth Drivers

• Increasing Prevalence of Hemorrhoidal Disease
  Lifestyle patterns in GCC, including low-fiber diets, sedentary work, obesity, and rising stress levels, are contributing to a growing incidence of hemorrhoidal disease. Aging populations and higher rates of pregnancy-related hemorrhoids also add to the patient pool requiring medical attention. As the number of symptomatic patients rises, the proportion of individuals who progress to surgical intervention naturally increases. This creates a sustained base of demand for hemorrhoid-specific surgical devices, particularly in secondary and tertiary care centers. Over time, the cumulative effect of these risk factors ensures stable, long-term market growth for device-based treatment options.

• Expansion of Colorectal and Proctology Specialties
  The development of dedicated colorectal surgery and proctology departments in hospitals across GCC is significantly driving adoption of advanced hemorrhoids surgical devices. Specialized units tend to invest more aggressively in state-of-the-art staplers, energy systems, and visualization tools to support complex anorectal procedures. Training programs for colorectal surgeons often emphasize minimally invasive techniques, aligning clinical practice with modern device usage. As more specialists enter the workforce and sub-specialty recognition grows, procedural capacity and throughput increase. This structural expansion of the specialty creates a fertile environment for sustained device demand.

• Technological Innovation in Surgical Instruments and Visualization
  Continuous improvements in device design, ergonomics, and visualization technologies are making hemorrhoid surgery safer, more efficient, and more predictable. Modern staplers feature refined staple lines and improved firing mechanisms, while doppler-guided ligation systems enable precise identification of feeding vessels. High-resolution anoscopes and imaging systems enhance intraoperative visualization, reducing technical errors. These innovations increase surgeon confidence and can shorten learning curves for new techniques. As devices become more intuitive and standardized, hospitals and clinics in GCC are more willing to adopt them widely, which in turn fuels market growth.

• Shift Toward Day-Care Surgery and Cost-Efficient Care Models
  Healthcare systems in GCC are under pressure to reduce inpatient costs and optimize resource utilization, driving a shift toward day-care surgical models. Minimally invasive hemorrhoid procedures are well-suited to these models, offering rapid recovery and low postoperative complication rates when performed with appropriate devices. Ambulatory surgery centers and hospitals benefit from improved bed turnover, while patients appreciate the convenience of same-day discharge. This alignment of economic and clinical incentives makes investment in hemorrhoids surgical devices attractive for providers. As reimbursement structures evolve to support day-care procedures, the growth trajectory for related devices strengthens further.

• Improved Reimbursement and Coverage for Minimally Invasive Procedures
  In many parts of GCC, payers and public health systems are gradually expanding coverage for device-based hemorrhoid procedures, recognizing their long-term cost-effectiveness. Reduced recurrence rates, fewer complications, and shorter hospital stays contribute to better overall value profiles compared with traditional surgery. As reimbursement codes and tariffs are updated to reflect these benefits, both clinicians and patients are more inclined to choose technologically advanced options. This financial support lowers access barriers, particularly for middle-income patients who might otherwise delay or avoid surgery. Over time, favorable reimbursement environments are expected to be a major catalyst for device market growth.

Challenges in the Market

• High Cost of Advanced Surgical Devices and Procedures
  Advanced hemorrhoids surgical devices, including staplers, doppler-guided systems, and laser platforms, come with significant acquisition and per-procedure costs. In GCC, these expenses can be a major barrier for smaller hospitals, ambulatory centers, and patients with limited insurance coverage. Facilities may hesitate to adopt newer technologies if cost recovery is uncertain or reimbursement rates are low. Patients may also opt for older, more painful procedures or defer treatment entirely due to financial concerns. This cost sensitivity can slow the pace of transition toward minimally invasive, device-intensive techniques even when clinical benefits are clear.

• Limited Availability of Trained Colorectal Surgeons and Proctologists
  Effective use of hemorrhoids surgical devices often requires specialized training in minimally invasive anorectal procedures. In many regions of GCC, there is a shortage of colorectal surgeons and proctologists with experience in advanced stapling or energy-based techniques. General surgeons may still depend on conventional excisional hemorrhoidectomy due to familiarity and limited device training. This skills gap restricts patient access to the full range of modern treatment options, reducing potential device uptake. Expanding formal training programs and proctorship initiatives remains a critical requirement to unlock market potential.

• Concerns About Complications and Long-Term Outcomes
  Although minimally invasive procedures offer advantages, they are not entirely free of complications such as bleeding, stenosis, or persistent symptoms. In GCC, reports of adverse outcomes—particularly when devices are misused or used in inappropriate indications—can create skepticism among clinicians and patients. Debates in scientific literature regarding recurrence rates and long-term durability of certain techniques also influence practice patterns. These concerns can make some providers cautious about rapid adoption of newer devices, preferring more established approaches. Manufacturers must therefore invest in robust clinical data, surgeon education, and clear indication guidelines to address these perceptions.

• Regulatory and Procurement Barriers
  Hemorrhoids surgical devices are subject to stringent regulatory evaluations that can prolong time-to-market and increase development costs. In GCC, navigating registration requirements, quality audits, and post-market surveillance obligations is complex, especially for smaller manufacturers. Public hospitals and government institutions often have lengthy, price-focused tender processes that may not fully reward innovation. Procurement delays and restrictive formularies can hinder access to newer technologies even when clinicians express demand. These regulatory and procurement challenges collectively slow market penetration for advanced devices.

• Stigma and Under-Reporting of Hemorrhoid Symptoms
  Despite rising awareness, many individuals in GCC still feel embarrassed to seek medical help for anorectal symptoms such as bleeding or prolapse. Cultural stigma and misconceptions about hemorrhoids being a minor or self-limiting condition lead to under-reporting and delayed diagnosis. As a result, fewer patients progress through formal diagnostic pathways that might eventually lead to surgical intervention. When patients do present, they may already have advanced disease that is more difficult to treat optimally. This behavioral barrier reduces the potential pool of candidates for surgical device-based procedures and limits the effective size of the addressable market.

GCC Hemorrhoids Surgical Devices Market Segmentation

By Product Type

• Hemorrhoidal Staplers

• Doppler-Guided Hemorrhoidal Artery Ligation Systems

• Laser and Radiofrequency Hemorrhoid Devices

• Rubber Band Ligation Devices and Kits

• Electrosurgical Units and Accessories

• Proctoscopes and Anoscopes

• Others

By Procedure Type

• Stapled Hemorrhoidopexy

• Doppler-Guided Hemorrhoidal Artery Ligation (DGHAL)

• Laser Hemorrhoidoplasty / Energy-Based Procedures

• Conventional Excisional Hemorrhoidectomy (Device-Assisted)

• Rubber Band Ligation

• Others

By End-User

• Hospitals

• Ambulatory Surgical Centers

• Specialty Proctology and Colorectal Clinics

• Others

Leading Key Players

• Johnson & Johnson (Ethicon)

• Medtronic plc

• Intuitive Surgical, Inc.

• Olympus Corporation

• CONMED Corporation

• B. Braun Melsungen AG

• Cook Medical

• Smith & Nephew plc

• Teleflex Incorporated

• Karl Storz SE & Co. KG

Recent Developments

• Johnson & Johnson (Ethicon) introduced an upgraded circular stapler line for stapled hemorrhoidopexy procedures tailored to high-volume surgical centers in GCC.

• Medtronic plc expanded its energy-based surgery portfolio with radiofrequency systems optimized for minimally invasive hemorrhoid treatment in GCC.

• Olympus Corporation launched advanced proctoscopy and imaging solutions to enhance visualization during anorectal surgeries in GCC.

• CONMED Corporation partnered with leading colorectal surgeons in GCC to provide training workshops on device-assisted hemorrhoidectomy techniques.

• B. Braun Melsungen AG strengthened its presence in GCC by adding hemorrhoids surgical instruments and ligation kits to its colorectal surgery product range.

This Market Report Will Answer the Following Questions

1. What is the projected size and CAGR of the GCC Hemorrhoids Surgical Devices Market by 2031?

2. How are minimally invasive and energy-based procedures influencing device demand in GCC?

3. Which product types and end-user segments are expected to contribute most to market growth?

4. What key challenges related to cost, training, and regulation could restrain wider adoption of advanced hemorrhoid surgical devices?

5. Who are the leading companies in this market, and how are they expanding their footprint and product offerings in GCC?